Andrew Kocab 5/31/21 Andrew Kocab 5/31/21

Building Better Vaccines: Iaso Therapeutics

Learning how Iaso Therapeutics is developing a new vaccine platform to protect us from new and existing disease threats.

Andrew Kocab 5/2/21 Andrew Kocab 5/2/21

Creating a Company Around Genetically Engineered Probiotics: ZBiotics & Zack Abbott, PhD

Zack’s journey to creating a company and the world’s first genetically engineered probiotic.

Andrew Kocab 4/19/20 Andrew Kocab 4/19/20

A second dive into the Michigan drug development ecosystem.

Andrew Kocab 2/22/20 Andrew Kocab 2/22/20

Michigan startup that’s designing a better cancer drug.

Andrew Kocab 2/3/20 Andrew Kocab 2/3/20

A dive into NIH grant award data to gain insight into the ecosystem for Michigan-based therapeutics companies.

Andrew Kocab 11/22/19 Andrew Kocab 11/22/19

Developing health monitoring devices with graphene.

Andrew Kocab 10/24/19 Andrew Kocab 10/24/19

ONL Therapeutics recently achieved a milestone. This was also a milestone in my career, one that had more emotional impact than I expected.

Andrew Kocab 9/10/19 Andrew Kocab 9/10/19

Highlighting a company that’s working to protect the vision of patients with retinal disease.